Intelligent MnO 2 /Cu 2- x S for Multimode Imaging Diagnostic and Advanced Single-Laser Irradiated Photothermal/Photodynamic Therapy.

Yu Cao,Xiangdan Meng,Dongdong Wang,Kai Zhang,Wenhao Dai,Haifeng Dong,Xueji Zhang
DOI: https://doi.org/10.1021/acsami.8b05050
IF: 9.5
2018-01-01
ACS Applied Materials & Interfaces
Abstract:Lately, photothermal therapy (PTT) and photodynamic therapy (PDT) dual-modal therapy has attracted much attention in cancer therapy as a synergistic therapeutic model. However, the integration of PDT and PTT in single nanoagent for cancer therapy is still a challenging task. Herein, an intelligent MnO2/Cu2-xS-siRNA nanoagent simultaneously overcoming inherent limitations of PDT and PTT with remarkable PTT/PDT therapeutic efficiency enabling multimode accurate tumor imaging diagnostic is designed. We first develop a general method to decorate Cu2-xS on the surface of MnO2 nanosheet (MnO2/Cu2-xS), then, it was loaded with heat shock protein (HSP) 70 siRNA to obtain MnO2/Cu2-xS-siRNA. The intracellular microRNA (miRNA) imaging can be realized by loading miRNA detection probes. In the tumor acidic microenvironment, the MnO2 is reduced to Mn2+ ion, and trigger the decomposition of H2O2 into O2 to relieve tumor hypoxia. The reduced Mn2+ ions significantly enhance magnetic resonance imaging (MRI) contrast and the Cu2-xS acts as a powerful photoacoustic (PA) and photothermal (PT) imaging agent, leading to tri-modal accurate tumor-specific imaging and detection. Under a single NIR laser irradiation, the nanosystem exhibits superiority of PTT/PDT efficiency owing to siRNA-mediated blocked heat-shock response and MnO2-related relieved tumor hypoxia. This work highlights the great promise of modulating tumor cellular defense mechanism and microenvironment with intelligent multifunctional nanoagents to achieve a comprehensive fighting cancer effect.
What problem does this paper attempt to address?